Antitrust & Competition Life Sciences Quarterly Update - Q1 2023 | Goodwin

Our prior updates covered how FTC enforcement activity largely proceeded “as usual” during 2022 in the life sciences industry, with large pharmaceutical players buying or licensing...

Related Keywords

Illinois ,United States ,Noah Joshua Phillips ,Christines Wilson ,Christine Wilson ,Lina Khan ,Josephj Simons ,Abbvie Allergan ,Elizabeth Warren ,Noah Philip ,Biden Mar ,Us Senate Committee On Commerce ,Agency Scrutiny ,Abbvie Inc ,Amgen ,Pharmacy Task ,Allergan ,Pfizer ,Transactions Dominate ,Receive Agency ,Seagen Represents ,Largest Deal Since ,Horizon Therapeutics ,Republican Commissioner Christine Wilson ,Wall Street Journal ,President Biden ,Chair Lina Khan ,Pharmacy Benefit Manager Transparency Act ,Bernie Sanders ,Bill Cassidy ,Pharmacy Benefit Manger Reform Act ,Pfizer Sees Cancer Specialist Seagen ,Goose Laying ,Fierce Pharma ,Allergan Score ,Merger With One Final Hurdle Left ,Federal Trade Commission ,Chairman Joseph ,Commissioner Noah Joshua Phillips ,Commissioner Christine ,Proposed Acquisition ,Buy Horizon Therapeutics ,Trade Commission ,Block Biopharmaceutical Giant Amgen ,Treat Two Serious ,Him Resigning ,Push Mcconnell ,Benefit Manager Transparency ,Inquiry Into Prescription Drug Middlemen Industry ,